Home > María-Victoria Mateos, EHA 2020: TOURMALINE-MM4 study
Multiple Myeloma

María-Victoria Mateos, EHA 2020: TOURMALINE-MM4 study

Published Online: July 6th 2020

Dr María-Victoria Mateos, (Associate Professor of Medicine, Director of Myeloma Unit, University Hospital of Salamanca, Salamanca, Spain) explores unmet needs in the treatment of patients with newly-diagnosed multiple myeloma, and discusses the major findings of the TOURMALINE-MM4 study and the potential of ixazomib in patients no undergoing autologous stem cell transplant.

Questions:

  1. What are the limitations of current options for maintenance therapy in patients with newly-diagnosed multiple myeloma not undergoing autologous stem cell transplant (ASCT)? (0:04)
  2. What is the mechanism of action of ixazomib, and what precautions are associated with its use? (1:05)
  3. Could you give us an overview of the concept of switch maintenance, and the design of the TOURMALINE-MM4 study? (2:03)
  4. What were the major efficacy and safety findings of this study? (5:06)
  5. What have the other TOURMALINE studies taught us about the use of ixazomib in the treatment of multiple myeloma? (8:39)

Abstract S200, Ixazomib vs Placebo as Post-Induction Maintenance Therapy in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Not Undergoing Autologous Stem C Transplant (ASCT): Phase 3 TOURMALINE-MM4 Trial, was presented at EHA25 Virtual, June 2020.

Speaker disclosure: The TOURMALINE-MM4 study was supported by Takeda.

Support: Interview and filming supported by Touch Medical Media in collaboration with W20 Group.

Filmed at the Virtual Edition of the 25th European Hematology Association Annual Congress (EHA25 Virtual), June 2020.

Related Videos In Multiple Myeloma
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar